These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 34561086)

  • 21. Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva.
    Yoon JG; Yoon J; Song JY; Yoon SY; Lim CS; Seong H; Noh JY; Cheong HJ; Kim WJ
    J Korean Med Sci; 2020 May; 35(20):e195. PubMed ID: 32449329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of oral antiseptics on the viral load of SARS-CoV-2: A randomized controlled trial.
    Sevinç Gül SN; Dilsiz A; Sağlık İ; Aydın NN
    Dent Med Probl; 2022; 59(3):357-363. PubMed ID: 35904769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Cetylpyridinium Chloride mouthwash against SARS-CoV-2: A systematic review of randomized controlled trials.
    D'Amico F; Moro M; Saracino M; Marmiere M; Cilona MB; Lloyd-Jones G; Zangrillo A
    Mol Oral Microbiol; 2023 Jun; 38(3):171-180. PubMed ID: 36808889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlorhexidine mouthwash reduces the salivary viral load of SARS-CoV-2: A randomized clinical trial.
    Costa DD; Brites C; Vaz SN; de Santana DS; Dos Santos JN; Cury PR
    Oral Dis; 2022 Nov; 28 Suppl 2():2500-2508. PubMed ID: 34837305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective
    Davies K; Buczkowski H; Welch SR; Green N; Mawer D; Woodford N; Roberts ADG; Nixon PJ; Seymour DW; Killip MJ
    J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of antiseptic mouthrinses against SARS-CoV-2: A prospective randomized placebo-controlled pilot study.
    Fantozzi PJ; Pampena E; Pierangeli A; Oliveto G; Sorrentino L; Di Vanna D; Pampena R; Lazzaro A; Gentilini E; Mastroianni CM; D'Ettorre G; Polimeni A; Romeo U; Villa A
    Am J Otolaryngol; 2022; 43(6):103549. PubMed ID: 35988522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral antiseptics against coronavirus: in-vitro and clinical evidence.
    Mateos-Moreno MV; Mira A; Ausina-Márquez V; Ferrer MD
    J Hosp Infect; 2021 Jul; 113():30-43. PubMed ID: 33865974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized clinical trial to assess the impact of oral intervention with cetylpyridinium chloride to reduce salivary SARS-CoV-2 viral load.
    Tarragó-Gil R; Gil-Mosteo MJ; Aza-Pascual-Salcedo M; Alvarez MJL; Ainaga RR; Gimeno NL; Viñuales RF; Fernández YM; Marco JM; Bolsa EA; Sancho JB; Cajo SA; Perez-Zsolt D; Raïch-Regué D; Muñoz-Basagoiti J; Izquierdo-Useros N; Pociello VB; León R; Peris DS
    J Clin Periodontol; 2023 Mar; 50(3):288-294. PubMed ID: 36345827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of mouth rinses against COVID-19: a systematic review and network meta-analysis.
    Lin SY; Sun JS; Hung MC; Chang JZ
    J Hosp Infect; 2023 Sep; 139():175-191. PubMed ID: 37419189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eligibility and efficacy of a CPC- and CHX-based antiviral mouthwash for the elimination of SARS-CoV-2 from the saliva: A randomized, double-blind, controlled clinical trial.
    Brunello G; Wolf V; Kerberger R; Bernhard M; Lübke N; Becker J; Schwarz-Herzke B; Timm J; Becker K
    J Clin Periodontol; 2024 Feb; 51(2):158-166. PubMed ID: 38058254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial.
    Eduardo FP; Corrêa L; Heller D; Daep CA; Benitez C; Malheiros Z; Stewart B; Ryan M; Machado CM; Hamerschlak N; Rebello Pinho JR; Bezinelli LM
    Heliyon; 2021 Jun; 7(6):e07346. PubMed ID: 34189331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is chlorhexidine mouthwash effective in lowering COVID-19 viral load? A systematic review.
    Rahman GS; Alshetan AAN; Alotaibi SSO; Alaskar BMI; Baseer MA
    Eur Rev Med Pharmacol Sci; 2023 Jan; 27(1):366-377. PubMed ID: 36647885
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Nazrine S; Kulal R; Shivaprasad BM; Janardhanan N
    J Indian Soc Periodontol; 2023; 27(6):607-611. PubMed ID: 38434502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral effect of mouthwashes against SARS-COV-2: A systematic review.
    Mezarina Mendoza JPI; Trelles Ubillús BP; Salcedo Bolívar GT; Castañeda Palacios RDP; Herrera Lopez PSG; Padilla Rodríguez DA; Uchima Koecklin KH
    Saudi Dent J; 2022 Mar; 34(3):167-193. PubMed ID: 35125835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of povidone as a mouthrinse to decrease the viral load of Covid-19 before dental care: Review of the literature.
    Mendez J; Villasanti U
    Am J Dent; 2020 Oct; 33(5):248-250. PubMed ID: 33017527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Respiratory Aerosols Emitted by Patients With Coronavirus Disease 2019 (COVID-19) While Breathing, Talking, and Singing.
    Coleman KK; Tay DJW; Tan KS; Ong SWX; Than TS; Koh MH; Chin YQ; Nasir H; Mak TM; Chu JJH; Milton DK; Chow VTK; Tambyah PA; Chen M; Tham KW
    Clin Infect Dis; 2022 May; 74(10):1722-1728. PubMed ID: 34358292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virucidal Properties of Molecular Iodine Oral Rinse Against SARS-CoV-2.
    Teagle V; Clem DS; Yoon T
    Compend Contin Educ Dent; 2022 Feb; 43(2):e13-e16. PubMed ID: 35148480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of mouthwashes on reducing SARS-CoV-2 viral load in oral cavity: a systematic review and meta-analysis.
    Ebrahimi T; Shamshiri AR; Alebouyeh M; Mohebbi SZ
    BMC Oral Health; 2023 Jul; 23(1):443. PubMed ID: 37400836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
    Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
    Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.